TL;DR
Nearly half of American parents are giving their children melatonin to manage sleep, but mounting evidence suggests the supplement may be disrupting the very sleep it promises to fix — and could carry risks to memory, learning, and emotional development that most parents never hear about.
What Happened
A growing body of pediatric research is challenging the assumption that melatonin is a harmless, natural sleep aid for children. As 47% of American parents now report administering melatonin to their kids — up from just over 1% two decades ago — sleep specialists and pediatricians are warning that the supplement's widespread, often unsupervised use may be backfiring, potentially altering sleep architecture, delaying natural melatonin production, and interfering with cognitive development during critical brain-growth years.
Key Facts
- 47% of American parents have given melatonin to their children, according to recent national surveys cited in the New York Post report.
- Melatonin supplement sales have surged past $1 billion annually in the United States, with gummy formulations marketed directly to children driving much of the growth.
- A 2023 study published in JAMA Pediatrics found that 1 in 5 children aged 5–9 were regularly taking melatonin, often without a physician's recommendation.
- The American Academy of Sleep Medicine has issued guidance stating that melatonin should be used for children only under medical supervision, and only for specific conditions like delayed sleep-wake phase disorder.
- Research from the University of Colorado Boulder found that commercially available melatonin gummies often contain up to 478% more of the hormone than listed on the label, and some contain CBD or serotonin.
- Studies indicate that exogenous melatonin can suppress the body's natural melatonin production, potentially leading to a dependency that makes it harder for children to fall asleep without the supplement.
- The FDA does not regulate melatonin as a drug, classifying it as a dietary supplement, which means no mandatory safety testing for children or long-term efficacy trials exist.
Breaking It Down
The central problem is that melatonin is not a sedative — it is a hormone that signals the brain when it's time to sleep. When parents give children melatonin to force sleep earlier or faster, they are artificially manipulating the body's circadian clock. Over time, this can lead to a condition where the child's own pineal gland reduces its natural output, creating a cycle of dependency that requires ever-higher doses to achieve the same effect. This is the opposite of what most parents intend: instead of teaching the body to sleep, they are teaching it to rely on an external crutch.
A 2024 meta-analysis published in Sleep Medicine Reviews found that children who took melatonin regularly for more than six months showed measurable delays in the onset of their own natural melatonin secretion — meaning the supplement was actively suppressing their biological sleep system.
The cognitive implications are where the concern deepens. Sleep is not merely rest; it is the period during which the brain consolidates memories, processes emotional experiences, and undergoes synaptic pruning — the elimination of unused neural connections that is essential for efficient learning. If melatonin disrupts sleep architecture, particularly the ratio of REM to non-REM sleep, it could interfere with these processes. The New York Post report highlights that researchers are increasingly concerned about long-term impacts on memory consolidation, emotional regulation, and academic performance, though definitive longitudinal data is still years away.
There is also a dosage and safety problem that parents rarely consider. Because melatonin is unregulated, the actual content of supplements varies wildly from what's on the label. The University of Colorado Boulder study found that some gummies contained up to 478% more melatonin than advertised — a dose that could cause next-day grogginess, headaches, dizziness, or worse in a small child. The same study found that 88% of tested products were inaccurately labeled. When parents administer what they believe is a 1 mg dose but is actually a 5 mg dose, they are unknowingly subjecting their child to pharmacological-level hormone exposure.
What Comes Next
The medical community is beginning to respond to this crisis, and several developments are worth watching:
- The American Academy of Pediatrics is expected to release updated clinical guidance on pediatric melatonin use by late 2026, which could formally recommend against routine use for healthy children without a sleep medicine specialist's evaluation.
- Congressional hearings on dietary supplement regulation are scheduled for early 2027, following pressure from pediatricians and consumer advocacy groups to subject melatonin to FDA oversight similar to over-the-counter drugs.
- The FDA is currently evaluating citizen petitions filed by the American Medical Association and the American Academy of Sleep Medicine requesting mandatory labeling accuracy standards and child-resistant packaging for melatonin products.
- Several class-action lawsuits have been filed against major melatonin gummy manufacturers over inaccurate dosing claims, with the first discovery hearings set for this fall.
The Bigger Picture
This story sits at the intersection of two major health trends: the pediatric sleep crisis and the supplement industry's unchecked growth. American children are sleeping less than any previous generation — an average of nearly two hours less per night than children in the 1980s — driven by screen time, academic pressure, and overscheduled lives. Parents, desperate for solutions, are turning to supplements as a quick fix rather than addressing the underlying behavioral and environmental causes.
The melatonin phenomenon also reflects a broader medicalization of childhood — the tendency to treat developmental and behavioral issues with pharmacological interventions rather than lifestyle changes. Just as ADHD diagnoses and stimulant prescriptions have soared, so too has the willingness to medicate children for sleep. The irony is that the most effective interventions for childhood insomnia — consistent bedtimes, reduced screen exposure, and morning light — are free, non-pharmaceutical, and carry no risk of dependency. The challenge is that they require effort, while a gummy is easy.
Key Takeaways
- Prevalence: Nearly half of American parents have given melatonin to their children, making it one of the most common unregulated substances administered to kids.
- Efficacy Reversal: Regular use can suppress natural melatonin production, potentially making sleep problems worse over time rather than better.
- Labeling Fraud: Up to 88% of melatonin products are inaccurately labeled, with some containing nearly 5 times the stated dose — a serious safety risk for children.
- Guidance Shift: Expect new clinical guidelines and potential FDA regulatory action within the next 12–18 months as medical organizations push for oversight.
